Literature DB >> 31773399

ANRIL Variants Are Associated with Risk of Neuropsychiatric Conditions.

Amir Namvar1, Mir Salar Kahaei1, Hamid Fallah1, Fwad Nicknafs1, Soudeh Ghafouri-Fard2, Mohammad Taheri3.   

Abstract

The antisense non-coding RNA in the INK4 locus (ANRIL) is a long non-coding RNA (lncRNA) whose contribution in several human disorders has been verified. In the current projects, we genotyped two single nucleotide polymorphisms (SNPs) in this lncRNA (rs1333045 and rs1333048) in a population of Iranian patients with bipolar disorder (BP), major depressive disorder (MDD), and methamphetamine addiction. The rs1333045 was associated with methamphetamine addiction in recessive and multiplicative models (OR (95% CI) = 1.867 (1.211-2.877), adjusted p value = 8.75E-03 and OR (95% CI) = 1.415 (1.089-1.839), adjusted p value = 1.87E-02 respectively). The rs1333048 was associated with methamphetamine addiction in co-dominant model (A/A vs. C/C: OR (95% CI) = 0.195 (0.114-0.336), adjusted p value = 2.44E-09) and in other inheritance models. The rs1333045 was not associated with risk of BP I in any inheritance model. However, the rs1333048 was associated with BP I in co-dominant model (A/A vs. C/C: OR (95% CI) = 0.499 (0.286-0.870), adjusted p value = 2.53E-07) and in other inheritance models. In BP II cohort, we detected significant associations between both SNPs and risk of disorder in all inheritance models. In co-dominant model, these associations were detected just between homozygotes (T/T vs. C/C (rs1333045); A/A vs. C/C and (rs1333048)). The rs1333045 was associated with MDD in recessive model (OR (95% CI) = 2.221 (1.173-4.207), adjusted p value = 0.026). The rs1333048 was associated with MDDs in dominant, recessive, and multiplicative models. The selected SNPs were not in linkage disequilibrium (D' statistic = 0.23, r2 = 0.05). Haplotype analyses have shown that T A haplotype block (rs1333045 and rs1333048 respectively) significantly decreases risk of addiction, BP I, BP II, and MDD. Besides, the C C haplotype decreases risk of addiction, BP II and MDD. Finally, the T C haplotype increases risk of BP I, BP II, and MDD. Based on the above-mentioned data, the selected ANRIL SNPs or other SNPs in linkage disequilibrium with them might confer risk of neuropsychiatric disorders. Taken together, ANRIL can be regarded as a risk locus for these conditions.

Entities:  

Keywords:  ANRIL; Antisense non-coding RNA in the INK4 locus; Bipolar disorder; Major depressive disorder; Methamphetamine addiction; rs1333045; rs1333048

Mesh:

Substances:

Year:  2019        PMID: 31773399     DOI: 10.1007/s12031-019-01447-0

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  20 in total

Review 1.  Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.

Authors:  Harvey A Whiteford; Louisa Degenhardt; Jürgen Rehm; Amanda J Baxter; Alize J Ferrari; Holly E Erskine; Fiona J Charlson; Rosana E Norman; Abraham D Flaxman; Nicole Johns; Roy Burstein; Christopher J L Murray; Theo Vos
Journal:  Lancet       Date:  2013-08-29       Impact factor: 79.321

2.  Chromosome 9p21.3 genotype is associated with vascular dementia and Alzheimer's disease.

Authors:  Enzo Emanuele; Simone Lista; Roberta Ghidoni; Giuliano Binetti; Cristina Cereda; Luisa Benussi; Raffaele Maletta; Amalia C Bruni; Pierluigi Politi
Journal:  Neurobiol Aging       Date:  2009-08-06       Impact factor: 4.673

Review 3.  ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS.

Authors:  Eric Pasmant; Audrey Sabbagh; Michel Vidaud; Ivan Bièche
Journal:  FASEB J       Date:  2010-10-18       Impact factor: 5.191

4.  Shared genetic factors influence risk for bipolar disorder and alcohol use disorders.

Authors:  N Carmiol; J M Peralta; L Almasy; J Contreras; A Pacheco; M A Escamilla; E E M Knowles; H Raventós; D C Glahn
Journal:  Eur Psychiatry       Date:  2013-12-08       Impact factor: 5.361

5.  Down-regulated long non-coding RNA ANRIL restores the learning and memory abilities and rescues hippocampal pyramidal neurons from apoptosis in streptozotocin-induced diabetic rats via the NF-κB signaling pathway.

Authors:  Xin Wen; Xin-Rui Han; Yong-Jian Wang; Shan Wang; Min Shen; Zi-Feng Zhang; Shao-Hua Fan; Qun Shan; Liang Wang; Meng-Qiu Li; Bin Hu; Chun-Hui Sun; Dong-Mei Wu; Jun Lu; Yuan-Lin Zheng
Journal:  J Cell Biochem       Date:  2018-03-30       Impact factor: 4.429

6.  Inflammatory cytokines and nuclear factor-kappa B activation in adolescents with bipolar and major depressive disorders.

Authors:  David J Miklowitz; Larissa C Portnoff; Casey C Armstrong; Danielle Keenan-Miller; Elizabeth C Breen; Keely A Muscatell; Naomi I Eisenberger; Michael R Irwin
Journal:  Psychiatry Res       Date:  2016-05-07       Impact factor: 3.222

7.  Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA.

Authors:  Wenqiang Yu; David Gius; Patrick Onyango; Kristi Muldoon-Jacobs; Judith Karp; Andrew P Feinberg; Hengmi Cui
Journal:  Nature       Date:  2008-01-10       Impact factor: 49.962

Review 8.  Neuronal migration, apoptosis and bipolar disorder.

Authors:  Ezequiel Uribe; Richard Wix
Journal:  Rev Psiquiatr Salud Ment       Date:  2012-01-20       Impact factor: 3.318

9.  ANRIL Genetic Variants in Iranian Breast Cancer Patients.

Authors:  Hamid Reza Khorshidi; Mohammad Taheri; Rezvan Noroozi; Shaghayegh Sarrafzadeh; Arezou Sayad; Soudeh Ghafouri-Fard
Journal:  Cell J       Date:  2017-05-17       Impact factor: 2.479

Review 10.  Addiction, Anhedonia, and Comorbid Mood Disorder. A Narrative Review.

Authors:  Marianne Destoop; Manuel Morrens; Violette Coppens; Geert Dom
Journal:  Front Psychiatry       Date:  2019-05-22       Impact factor: 4.157

View more
  2 in total

Review 1.  Epigenetic Modulation of Opioid Receptors by Drugs of Abuse.

Authors:  Ke Zhang Reid; Brendan Matthew Lemezis; Tien-Chi Hou; Rong Chen
Journal:  Int J Mol Sci       Date:  2022-10-05       Impact factor: 6.208

Review 2.  Genetics of methamphetamine use disorder: A systematic review and meta-analyses of gene association studies.

Authors:  Alexandre A Guerin; Eric J Nestler; Michael Berk; Andrew J Lawrence; Susan L Rossell; Jee Hyun Kim
Journal:  Neurosci Biobehav Rev       Date:  2020-11-17       Impact factor: 8.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.